Materialise NV Highlights Margin Gains in Earnings Call

Materialise NV ((MTLS)) has held its Q1 earnings call. Read on for the main highlights of the call.

Materialise NV’s latest earnings call painted a cautiously upbeat picture, with management highlighting resilient revenue, expanding margins, and sharply higher profitability despite foreign exchange pressure and a soft macro backdrop. Investors also heard about solid medical growth, progress in software subscriptions, a healthier balance sheet, and portfolio moves designed to sharpen the company’s strategic focus, even as some manufacturing end markets remain weak.

Stable Revenue with Margin Expansion

Materialise reported first-quarter revenue of EUR 66.3 million, flat year-on-year, but delivered a notable improvement in profitability through stronger unit economics. Gross profit increased to EUR 37.9 million and gross margin expanded to 57.2%, up from 55.3% a year earlier, underscoring the company’s ability to protect pricing and mix even as top-line growth paused.

Material Improvement in Profitability

Operating performance strengthened meaningfully, with adjusted EBITDA rising more than 30% to EUR 8.0 million, equivalent to a 12.1% margin. Adjusted EBIT climbed to EUR 2.5 million, or a 3.7% margin, versus EUR 0.6 million in the prior-year quarter, and net profit reached EUR 1.8 million, translating into earnings of EUR 0.03 per share.

Medical Segment Growth and Product Launches

The Medical segment provided a key growth engine, with revenue up 7% to EUR 33.2 million, and close to 10% on a constant currency basis, while Medical Devices grew around 11%. Management spotlighted launches of custom-made PEEK cranio-maxillofacial implants, now available across most of Europe, and the OrthoView 3D Hip solution, which expands CT-based planning and strengthens the company’s integrated medical ecosystem.

Software Business Progress and Recurring Revenue

Software revenue came in at EUR 9.6 million, down 1% on a reported basis but up about 5% in constant currency terms as FX masked underlying momentum. Recurring revenue rose to 83% of software sales, compared with 81% a year earlier, while adjusted EBITDA in the segment jumped 88% to EUR 1.1 million, reflecting growing operating leverage in the shift to cloud and subscription models.

Strategic Partnerships and Product Distribution Wins

Materialise highlighted strategic partnerships as a key growth driver, particularly an expanded collaboration with HP that will see Magics Print for HP bundled with the new MJF 1200 printer, opening access to lower and mid-range 3D printing users. The company also reported progress with CO‑AM Professional, noting early-access and presales activity with seven customers now onboarding, ahead of broader commercial availability expected in 2026.

Manufacturing Sequential Improvement in Strategic Areas

Manufacturing revenue declined 8% year-on-year to EUR 23.5 million but showed sequential recovery compared with the prior three quarters, signaling some stabilization. Growth in strategic niches such as aerospace, defense, and semiconductor production helped offset broader weakness, and adjusted EBITDA for Manufacturing turned positive at EUR 0.3 million, indicating improving efficiency in the segment.

Strong Cash Position and Positive Free Cash Flow

The balance sheet remains a pillar of strength, with cash reserves of EUR 133 million against gross debt of EUR 60.1 million, resulting in net cash of EUR 72.8 million, up roughly EUR 2 million in the quarter. Operating cash flow reached about EUR 7 million, while capex stood at EUR 1.5 million, yielding free cash flow after investing activities of EUR 5.7 million and giving the company ample financial flexibility.

Sustainability and Reporting Milestones

Management also underscored progress on sustainability and governance, noting the publication of the first annual report following the Euronext listing and completion of CSRD-aligned reporting. Materialise exceeded its greenhouse gas reduction targets, cutting over 1,500 tons of CO2 over a rolling two-year period, including more than 450 tons annually from switching PA12 materials, while a solar park at headquarters now supplies over 40% of that site’s electricity.

Strategic Portfolio Repositioning

In a bid to sharpen its core focus, Materialise is transferring RapidFit and its eyewear business to their management teams, with the company retaining a minority stake in eyewear. These moves are expected to free capital and leadership attention for higher-priority segments, while allowing the spun-out operations more agility, even though they will reduce reported Manufacturing revenue in the near term.

Foreign Exchange Headwinds

Currency movements weighed on reported results, with a weaker U.S. dollar cited as a major factor behind headline softness in the Medical and Software divisions. Management emphasized that on a constant currency basis, both units delivered stronger growth than the reported figures suggest, highlighting the gap between operational performance and FX-translated numbers.

Manufacturing Decline and Weak Prototyping Demand

Despite sequential improvements, Manufacturing still faced an 8% year-on-year revenue drop, as macroeconomic weakness continued to pressure demand. Prototyping orders, especially from European automotive customers, remained under strain, underscoring the cyclical vulnerability of this part of the portfolio even as the company tilts more toward strategic, higher-value production work.

Reported Software Revenue Slightly Down

The Software unit’s reported 1% revenue decline to EUR 9.6 million reflects both FX headwinds and the growing pains of transitioning to cloud and subscriptions. Management argued that the underlying trajectory is healthier than the headline number, with constant currency growth and rising recurring revenue suggesting a more resilient, higher-margin software franchise over time.

Regional and End-Market Softness

Geographically, Europe remains a trouble spot, with automotive end markets in particular described as soft and weighing on demand for manufacturing and prototyping services. In contrast, U.S. markets show more signs of recovery, though budget cuts among academic and research customers there are hurting a smaller slice of the business and highlight uneven demand patterns across segments.

Top-Line Pressure from Divestments

The divestment of RapidFit and eyewear will create a measurable gap in manufacturing revenue, though the company did not disclose financial terms for those deals. Management believes the near-term drag on reported sales will be more than offset by improved profitability and strategic clarity, arguing that capital is better directed toward core areas with stronger structural growth.

Ongoing Macroeconomic and Geopolitical Uncertainty

Executives warned that macroeconomic and geopolitical uncertainty is likely to persist at least through 2026, maintaining pressure on demand visibility and currency translation. While the company is structuring its operations and portfolio around this backdrop, it acknowledged that volatility in end markets, especially in Europe, and FX rates could continue to complicate short-term comparisons.

Guidance and Outlook

Looking ahead, Materialise reaffirmed its full-year 2026 guidance for revenue of EUR 273–283 million and adjusted EBIT of EUR 10–12 million, despite the impact of divestments and a choppy macro environment. Management pointed to Q1 metrics, including a 57.2% gross margin, 12.1% adjusted EBITDA margin, net cash of EUR 72.8 million, EUR 61 million in deferred revenue and robust free cash flow, as evidence that the company is on track to meet its medium-term financial targets.

Materialise’s earnings call suggests a company successfully trading volume growth for quality and profitability, supported by a strong balance sheet and targeted strategic moves. While FX noise, manufacturing softness, and macro uncertainty remain credible risks, the improving margins, medical and software momentum, and reaffirmed guidance offer investors a constructive story anchored in disciplined execution rather than headline revenue expansion.